BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. - ROEverified

BCTX

Price:

$2.9

Market Cap:

$5.47M

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Beyond its flagship program, BriaCell has forged a collaborative research and development partnership with the National Cancer Institute (NCI). This alliance is dedicated to progressing Bria-OTS, a personalized immunotherapy designed for advanced breast cancer patients, and BriaDx, a proprietary diagnost...[Read more]

Industry

Biotechnology

IPO Date

2012-03-14

Stock Exchange

NASDAQ

Ticker

BCTX

The ROE as of June 2026 (TTM) for BriaCell Therapeutics Corp. (BCTX) is -147.92%

According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is -147.92%. This represents a change of 228.21% compared to the average of -45.07% of the last 4 quarters.

BriaCell Therapeutics Corp. (BCTX) Historical ROE (quarterly & annually)

How has BCTX ROE performed in the past?

The mean historical ROE of BriaCell Therapeutics Corp. over the last ten years is 7.71%. The current -147.92% ROE has changed -2019.34% with respect to the historical average. Over the past ten years (40 quarters), BCTX's ROE was at its highest in in the January 2023 quarter at 937.72%. The ROE was at its lowest in in the October 2018 quarter at -220.71%.

Quarterly (TTM)
Annual

Average

7.71%

Median

-99.19%

Minimum

-439.59%

Maximum

684.25%

BriaCell Therapeutics Corp. (BCTX) ROE by Quarter and Year

Discovering the peaks and valleys of BriaCell Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 420.42%

Maximum Annual ROE = 684.25%

Minimum Annual Increase = -306.86%

Minimum Annual ROE = -439.59%

Quarterly (TTM)
Annual
YearROEChange
2025-148.44%-173.81%
2024201.12%-62.58%
2023537.50%-306.86%
2022-259.84%420.42%
2021-49.93%-144.63%
2020111.87%-83.65%
2019684.25%-255.65%
2018-439.59%27.62%
2017-344.44%59.89%
2016-215.42%-6.90%

BriaCell Therapeutics Corp. (BCTX) Average ROE

How has BCTX ROE performed in the past?

The current ROE of BriaCell Therapeutics Corp. (BCTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

196.73%

5-year avg

56.08%

10-year avg

7.71%

BriaCell Therapeutics Corp. (BCTX) ROE vs. Peers

How is BCTX’s ROE compared to its peers?

BriaCell Therapeutics Corp.’s ROE is greater than Processa Pharmaceuticals, Inc. (-281.30%), less than Curis, Inc. (805.67%), greater than Entero Therapeutics, Inc. (-18.69%), greater than Leap Therapeutics, Inc. (-46.86%), greater than Palisade Bio, Inc. (-36.79%), greater than Hoth Therapeutics, Inc. (-165.25%), greater than Allarity Therapeutics, Inc. (-109.94%), less than Moleculin Biotech, Inc. (3.11%), less than Aspire Biopharma Holdings, Inc. (199.43%), greater than Citius Pharmaceuticals, Inc. (-67.42%),

Build a custom stock screener for BriaCell Therapeutics Corp. (BCTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BriaCell Therapeutics Corp. (BCTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is BriaCell Therapeutics Corp.'s ROE?

How is the ROE calculated for BriaCell Therapeutics Corp. (BCTX)?

What is the highest ROE for BriaCell Therapeutics Corp. (BCTX)?

What is the 3-year average ROE for BriaCell Therapeutics Corp. (BCTX)?

What is the 5-year average ROE for BriaCell Therapeutics Corp. (BCTX)?

How does the current ROE for BriaCell Therapeutics Corp. (BCTX) compare to its historical average?